Source:http://linkedlifedata.com/resource/lhgdn/association:55111
| Predicate | Object |
|---|---|
| lhgdn:found_in | |
| lhgdn:geneRifSource |
Lack of the NAT2*4 haplotype is strongly linked to adverse effects with sulfosalazine therapy in Japanese patients with rheumatoid arthritis.
|
| lhgdn:mesh_code |
D001172
|
| lhgdn:associationIdType | |
| lhgdn:umls_code |